Prosecution Insights
Last updated: October 04, 2026
Application No. 18/912,551

VASCULAR NETWORK INSPIRED FLUIDIC SYSTEM FOR SPATIOTEMPORAL REGULATION OF FLUID COMPONENTS

Non-Final OA §103§112
Filed
Oct 10, 2024
Priority
Oct 11, 2023 — provisional 63/589,549
Examiner
VARGOT, MATHIEU D
Art Unit
1742
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Advanced Biomedical Instrumentation Centre Limited
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
1y 6m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
752 granted / 1205 resolved
-2.6% vs TC avg
Strong +21% interview lift
Without
With
+20.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
21 currently pending
Career history
1227
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
51.2%
+11.2% vs TC avg
§102
12.0%
-28.0% vs TC avg
§112
25.2%
-14.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1205 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . 1.Applicant’s election without traverse of Group II, claims 26-28 in the reply filed on June 23, 2026 is acknowledged. 2.Claims 26-28 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 26, line 4, --of—should be inserted after “outside”. At lines 5 and 6 of claim 26, “the trans-wall molecules” lacks antecedent basis. Are these the same as the “flow-through molecules” set forth at line 5 of the claim? If so, consistent language should be used for the same elements being claimed. Also, the last four lines of claim 26 are confusing. It is unclear exactly what relation the confining of solutions to the outside of a specific channel has to immobilizing a local channel wall with enzymes and hence the recitation of these aspects separated by the term “or” is indefinite. Claim 26, last line, are the “vascular networks” the same as the “vascular-like channel system” set forth at line 1 of the claim? Again, consistent terminology should be used in the claims when referring to the same elements. Further, applicant uses the term “immobilized” at line 3 of claim 26 and “immobilizing” at line 5 thereof with respect to the channels or channel wall. However, the immobilizations are clearly different and this needs to be clarified in the claims—ie, a clear line of distinction should be made between these two different immobilizations. 3.The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 26-28 is/are rejected under 35 U.S.C. 103 as being unpatentable over the article entitled “Aquabots” by Zhu et al, ACS Nano 2022, 16, 13761-13770 (see page 13766, left side, under the heading “Interfacial Functionalization”). Zhu et al (see the last 2 lines of the left column of page 13766) discloses microfluidic channels that are semipermeable and functionalized by enzymes which allow for the breakdown of glucose. See lines 8-17 under the heading “Interfacial Functionalization” at page 13766, left side for the discussion of glucose breakdown and the transport of byproducts across the membrane wall. It is clear that solutions are confined to the exterior of the channel and that the channel is immobilized with an enzyme to alter flow through molecules that would facilitate the simulation of glucose absorption and metabolism in vascular networks since it is glucose that is being metabolized and the byproduct flowing through the membrane to the interior thereof. Also, it would be either inherent or obvious that the functionalizing of the membrane—with enzyme-- would occur at different regions of the channel since these regions would be the ones where glucose breakdown occurs The only claimed aspect apparently missing from Zhu et al is a solid substrate supporting the channels and affixed thereto. Given that Zhu et al prints the materials in the same manner as the instant to form the channels, it is submitted as completely obvious to one of ordinary skill in the art to provide a substrate onto which the materials are printed in Zhu et al to facilitate the formation of the channels. Indeed, there would almost have to be some form of substrate onto which the channel material is printed or otherwise it would be impossible to print the material. The materials recited in instant claim 27 are well known in the art—Official Notice is hereby taken of this—and such would have been obvious material selections for the channels in Zhu et al dependent on the exact physical properties desired for the channels. Instant claim 28 is submitted to have been within the skill level of the art in Zhu et al to facilitate the use of the channels as desired. 4.Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATHIEU D VARGOT whose telephone number is (571)272-1211. The examiner can normally be reached on Mon-Fri from 9 to 6. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Christina A Johnson, can be reached at telephone number 571 272-1176. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from Patent Center. Status information for published applications may be obtained from Patent Center. Status information for unpublished applications is available through Patent Center to authorized users only. Should you have questions about access to the USPTO patent electronic filing system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via a variety of formats. See MPEP § 713.01. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/InterviewPractice. /MATHIEU D VARGOT/Primary Examiner, Art Unit 1742
Read full office action

Prosecution Timeline

Oct 10, 2024
Application Filed
Sep 09, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728607
APPARATUS AND METHODS FOR MOLDING RIGID OCULAR LENSES
6y 1m to grant Granted Sep 08, 2026
Patent 12704746
OPHTHALMIC LENS AND OPHTHALMIC LENS TREATMENT METHOD
3y 11m to grant Granted Aug 11, 2026
Patent 12703160
METHODS AND SYSTEMS FOR MAKING AN OPTICAL FUNCTIONAL FILM
3y 7m to grant Granted Aug 11, 2026
Patent 12691650
METHOD TO MANUFACTURE A MOLD FOR LENSES, AND CORRESPONDING MOLD
2y 6m to grant Granted Jul 28, 2026
Patent 12692160
LASER-INDUCED CARBON NANOSTRUCTURES
1y 7m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
83%
With Interview (+20.9%)
3y 6m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1205 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month